PanGIA Logo


PanGIA Biotech

Early Detection is the CURE

PanGIA Biotech’s true liquid biopsy products are designed to meet the diverse needs of patients, physicians, and researchers. Our solutions are tailored to various cancer types, diseases, and disorders, ensuring accurate and actionable results.

By leveraging state-of-the-art technologies and rigorous quality control processes, the true liquid biopsy tests deliver exceptional sensitivity, specificity, and reliability. Whether you are looking for early cancer detection, therapy selection, monitoring treatment response, or detecting minimal residual disease, our products are designed to support patients throughout the entire journey.

Improved early detection of cancers, especially in early stages (Stage 1-2)

Improve quality of life

Drive wellness through earlier intervention